New Leukemia Drug Proven Effective

Wednesday, 09 Oct 2013 05:26 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
A pivotal trial of Gilead Sciences Inc's experimental drug idelalisib has been stopped early after independent monitors determined that the drug was shown to be effective.

The Phase 3 trial compared treatment with idelalisib and another drug, Rituxan, to treatment with Rituxan alone in patients with chronic lymphocytic leukemia who were not eligible for treatment with chemotherapy.

Idelalisib is part of a new class of medications designed to selectively block a type of protein known to promote tumor growth in certain types of blood cancer.
 
Gilead said an interim analysis by the Data Monitoring Committee overseeing the trial found that the drug had a significant impact on the length of time patients survived without their disease getting worse.
 
Gilead said it is discussing the trial results, and a potential regulatory filing, with the U.S. Food and Drug Administration.
 
The company filed last month for FDA approval of the drug as a treatment for non-Hodgkin's lymphoma.
 
Idelalisib patients in the recently stopped trial will continue receiving the drug, while others will be offered the option of switching to the experimental pill, Gilead said.
 

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
Privacy: We never share your email.
 
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Robotic Prostate Surgery Brings Higher Costs

Wednesday, 27 Aug 2014 12:43 PM

The introduction of robotic surgery for prostate cancer may have led to changes in the number of surgeons performing pro . . .

Genetic Discovery Gives Hope to Crohn's Patients

Wednesday, 27 Aug 2014 12:39 PM

A new genetic discovery about Crohn's disease could lead to different ways to fight the bowel disorder, researchers repo . . .

India Asks Pepsi to Cut Sugar

Wednesday, 27 Aug 2014 12:22 PM

India has asked US soft drinks giant PepsiCo to reduce the sugar content of its sodas as the country battles growing lev . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved